title: An overview of stress urinary incontinence treatment in women.
abstract: Stress urinary incontinence (SUI) is common in women, but it is under-reported and under-treated. We review here the management of SUI in women. Pelvic floor muscle training treats SUI in the majority of female patients, whereas anti-SUI devices are not widely accepted. Duloxetine has been approved for treating SUI. Suburethral slings have revolutionized the surgical management of SUI with durable efficacy, in contrast with injectable bulking agents.
authors.affiliation: Department of Urology, School of Medicine, University of Athens, Sismanoglio General Hospital of Athens, Athens, Greece. agpapatsoris@yahoo.gr
authors.forename: Athanasios G
authors.initials: AG
authors.lastname: Papatsoris
authors.forename: Michael
authors.initials: M
authors.lastname: Chrisofos
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Antoniou
authors.forename: Aristomenis
authors.initials: A
authors.lastname: Gekas
authors.forename: Charalambos
authors.initials: C
authors.lastname: Deliveliotis
mesh_terms: D000068736:Duloxetine Hydrochloride; D004558:Electric Stimulation; D005260:Female; D006801:Humans; D053580:Muscle Strength / Q000502:physiology; D017773:Pelvic Floor / Q000503:physiopathology*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D053825:Suburethral Slings; D013876:Thiophenes / Q000627:therapeutic use; D014550:Urinary Incontinence, Stress / Q000503:physiopathology* / Q000628:therapy*
chemical_list: D000068736:Duloxetine Hydrochloride; D017367:Selective Serotonin Reuptake Inhibitors; D013876:Thiophenes